2023 is a key year for the implementation of the "14th Five-Year Plan", how should pharmaceutical equipment companies do it?
Judging from the announcements disclosed by major leading pharmaceutical machinery companies in the New Year and the official public account release information, digital service upgrades, innovative development, improved delivery, and continued cultivation of the biomedical industry will be the direction and goal
of pharmaceutical machinery companies in 2023.
In 2023, what will pharmaceutical equipment companies do? (Image source: Pharma Network)
Innovative development
Under the background of the aging of the population, the gradual enhancement of residents' health awareness and the continuous upgrading of consumption levels, the consumption demand for pharmaceutical products and services will continue to increase, driving the market scale of the upstream pharmaceutical equipment industry to expand.
The industry expects that by 2025, the scale of China's pharmaceutical machine market will increase from the current nearly 100 billion yuan to 200 billion yuan
.
Policies such as the "14th Five-Year Plan" require accelerating the innovation-driven development and transformation of the pharmaceutical industry, and innovation will also become the only way
for pharmaceutical equipment enterprises.
On January 1, 2023, the chairman of Canaan Technology delivered a New Year's message, mentioning that 2023 is also a key year for Canaan's "Fifth Five-Year Plan", and the company should focus on long-term development, keep the pulse of the industry, grasp market opportunities, and forge a new engine
of high-quality development with innovation.
Digital service upgrades
With the increasingly fierce competition in the domestic pharmaceutical machine market, the pharmaceutical equipment industry has also ushered in a new stage
focusing on service quality improvement and brand value improvement.
At present, under the background of the rapid development of digital technology, digital service upgrading has also attracted more and more attention
from pharmaceutical enterprises.
For example, Dongfulong is working to realize the vision of "Deliverer of Smart Pharmaceutical Factories" and promote digital transformation
from the inside out.
Externally, the company is currently committed to providing customers with digital products and services, on January 1, 2023, Dongfulong announced on the official public account that the new [Dongfulong Service] official online platform will be launched, which will further realize service upgrades
.
According to reports, the service platform mainly serves customers at home and abroad to quickly apply for repair, accurate inquiry, progress inquiry, and will escort the normal use of customer equipment
.
The platform has four major functions, among which in the quick appointment service section, customers can choose the type of service they need for the bound equipment, compared with the traditional telephone communication method, this new way of communication cost is lower, service efficiency and service quality are also expected to be improved
.
Improve delivery
In the pharmaceutical equipment industry, improving delivery capabilities helps to meet customer expectations, and is conducive to pharmaceutical enterprises to grasp customer sensitive points, promote trust between pharmaceutical enterprises and customers, and enhance the competitiveness
of pharmaceutical enterprises in the market.
On January 11, 2023, the official public account of Chutian Technology released the news about the company's 2023 Model Worker Craftsman New Year Group Visit, in which the company's president's speech at the 2023 Manufacturing Delivery System Model Worker Spring Festival Group Meeting had many highlights, which mentioned that "the future will continue to increase investment", "meticulous", "quantity and quality run together and achieve perfect delivery" and other key information
about the development direction.
It pointed out that the delivery problem is a global problem, a systemic problem, and it is necessary to improve delivery, enhance delivery, and go all out to achieve perfect delivery
.
Continue to deepen the biomedical industry
China's biomedical industry is in a stage of rapid growth, and the market development prospects are considerable, but in the process of industrial development, it has exposed that there are still shortcomings in the upstream production equipment, raw materials, and consumables, and domestic pharmaceutical machinery companies need to continue to overcome the "stuck neck" link
.
In recent years, pharmaceutical enterprises including Chutian Technology and Dongfulong have actively deployed in the field of biomedicine, continued to increase investment in research and development, and accelerated the pace
of domestic substitution.
On January 6, 2023, Dongfulong launched the in-depth customization service
of disposable bioreactors on the official public account.
According to reports, the SUB bioreactor system designed for scalability and stability can meet the needs of customers from process development to large-scale biopharmaceutical production, and the current product specifications can provide 50-2000L
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
